Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

ISOPTO CETAPRED

PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM

Standard Dose
0.25%;10%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ISOPTO CETAPRED is listed in Drugs@FDA under application 087547 (ANDA).

Marketing status: Discontinued Active ingredient PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM Form and strength SUSPENSION;OPHTHALMIC - 0.25%;10% Sponsor ALCON Submission history Latest submission status date: 2000-04-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview ISOPTO CETAPRED is listed in Drugs@FDA under application 087547 (ANDA). Marketing status: Discontinued Active ingredient PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM Form and strength SUSPENSION;OPHTHALMIC - 0.25%;10% Sponsor ALCON Submission history Latest submission status date: 2000-04-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.